Tempest Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer treatment

The company is dedicated to advancing a portfolio of novel drug candidates that target various cancer types through both immunotherapy and small molecule approaches. Tempest Therapeutics aims to harness the body’s immune system and other biological mechanisms to combat tumors effectively, enhancing patient outcomes in oncology care. Through cutting-edge research and collaboration, the company seeks to address significant unmet medical needs in the fight against cancer.